For prostate cancer, the SEER data show a median age of 67 years at diagnosis, and for death from prostate cancer, 80 years. ... So the potential number of life-years saved by early detection and intervention is, on average, greater for breast cancer
Cabazitaxel (Jevtana), a chemotherapy drug used with prednisone for prostate cancer. ... It is the first treatment for advanced, hormone-refractory prostate cancer that has worsened during or after treatment with docetaxel.
men standing on a beach with the words “Free Prostate Cancer Screening” printed below in an attractive font. ... Preventive Services Task Force came out with their strongest statement ever, saying they recommended against prostate cancer screening.
and finally, (5) the nature of the nature/nurture debate and its pertinence to prostate cancer screening. ... 2) Prostate cancer is unpredictable. Most men who die after age 80 die with it, but not of it.
Preventive Services Task Force finding that prostate-specific antigen (PSA) screening for prostate cancer does more harm than good, the most frequent response I hear from physicians who continue to defend ... That's pretty much what we do by deploying
Sipuleucel-T (Provenge), autologous cellular immunotherapy approved to treat asymptomatic or minimally symptomatic prostate cancer that has spread to other parts of the body and is resistant to standard hormone treatment. ... cancer. Most of the studies
Researchers noted that total cancer rates were likely influenced by the increased surveillance for prostate-specific antigen and subsequent diagnoses of prostate cancer. ... The significant reduction in total cancer minus prostate cancer suggests that
That the connection to prostate cancer is unproven isn't a reason to take it. ... Too Much Fish Oil Might Boost Prostate Cancer Risk, Study Says (US News).
disease, with the rationale being that perhaps we will detect an early ovarian cancer? ... prostate cancer, cannot.
For example, prostate cancer screening has been in the news lately. ... More evidence suggests that screening for prostate cancer may not only be unnecessary but also potentially harmful.